MKK4 Inhibitors—Recent Development Status and Therapeutic Potential
MKK4 (mitogen-activated protein kinase kinase 4; also referred to as MEK4) is a dual-specificity protein kinase that phosphorylates and regulates both JNK (c-Jun N-terminal kinase) and p38 MAPK (p38 mitogen-activated protein kinase) signaling pathways and therefore has a great impact on cell prolife...
Main Authors: | Leon Katzengruber, Pascal Sander, Stefan Laufer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7495 |
Similar Items
-
Dual <i>Mkk4</i> and <i>Mkk7</i> Gene Deletion in Adult Mouse Causes an Impairment of Hippocampal Immature Granule Cells
by: Rubén Darío Castro-Torres, et al.
Published: (2021-09-01) -
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
by: Lorenzo Stramucci, et al.
Published: (2018-05-01) -
MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation
by: Rafael Romero-Becerra, et al.
Published: (2022-08-01) -
Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway
by: Lei Gu, et al.
Published: (2023-08-01) -
Crystal structure of the phosphorylated Arabidopsis MKK5 reveals activation mechanism of MAPK kinases
by: Pei Chao-Jun, et al.
Published: (2022-07-01)